Related stories
Sempra Expects Oncor’s 2027–2031 Capital Plan to Rise Roughly 20%
Sempra expects Oncor’s 2027–2031 capital plan to increase roughly 20% from the existing $47.5 billion plan.
M impact | EARNINGS | Nov 05, 2026, 05:09 PM UTC
BRIEF-Dino Q3 Net Profit At 483 Million Zlotys, Below Forecasts
BRIEF-Dino Q3 Net Profit At 483 Million Zlotys, Below Forecasts Nov 5 (Reuters) - Dino Polska S.A. D
L impact | EARNINGS | Nov 05, 2026, 05:08 PM UTC
ViroGates Nine-Month Revenue Jumps 75% on US Partner Orders
Denmark's ViroGates reported a 75% increase in revenue over nine months, attributed to orders from US partners.
M impact | EARNINGS | Nov 05, 2026, 05:08 PM UTC
International Bancshares Reports Strong Earnings for First Nine Months of 2026
M impact | EARNINGS | Nov 05, 2026, 05:08 PM UTC
Acadia Pharmaceuticals Sees Continued Daybue Momentum in Q3, RBC Says
12:07 PM EST, 11/05/2026 (MT Newswires) -- Acadia Pharmaceuticals (ACAD) reported Q3 results underpi
L impact | EARNINGS | Nov 05, 2026, 05:07 PM UTC
Enovis Climbs on Swing to 3Q Profit, Higher Sales
By Connor HartShares of Enovis gained after the medical-technology company swung to a profit and logged higher sales in the recent quarter, prompting it to raise its full-year outl
L impact | EARNINGS | Nov 05, 2026, 05:05 PM UTC